September 26, 2016 1:10 AM ET


Company Overview of KAI Pharmaceuticals, Inc.

Company Overview

KAI Pharmaceuticals, Inc. provides biopharmaceutical drug discovery and development services. The company develops KAI-4169, a calcium-sensing receptor agonist, as an intravenous bolus product for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) in patients with end-stage renal disease receiving hemodialysis. Its KAI-4169 is also being developed as a transdermal patch product for daily administration in the treatment of stage 3 and 4 CKD-MBD pre-dialysis patients; ESRD (Stage 5 kidney disease) patients receiving peritoneal dialysis; renal transplant patients with CKD-MBD; and primary hyperparathyroid patients who are ineligible or do not elect to undergo parathyroi...

270 Littlefield Avenue

South San Francisco, CA 94080-6924

United States

Founded in 2002





Key Executives for KAI Pharmaceuticals, Inc.

Chief Medical Officer and Senior Vice President of Development
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact KAI Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at